|
Atomistry » Bromine » PDB 3u2d-3wk9 » 3uli | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Bromine » PDB 3u2d-3wk9 » 3uli » |
Bromine in PDB 3uli: Human Cyclin Dependent Kinase 2 (CDK2) Bound to Azabenzimidazole DerivativeEnzymatic activity of Human Cyclin Dependent Kinase 2 (CDK2) Bound to Azabenzimidazole Derivative
All present enzymatic activity of Human Cyclin Dependent Kinase 2 (CDK2) Bound to Azabenzimidazole Derivative:
2.7.11.22; Protein crystallography data
The structure of Human Cyclin Dependent Kinase 2 (CDK2) Bound to Azabenzimidazole Derivative, PDB code: 3uli
was solved by
N.A.Larsen,
J.A.Tucker,
T.Wang,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Bromine Binding Sites:
The binding sites of Bromine atom in the Human Cyclin Dependent Kinase 2 (CDK2) Bound to Azabenzimidazole Derivative
(pdb code 3uli). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the Human Cyclin Dependent Kinase 2 (CDK2) Bound to Azabenzimidazole Derivative, PDB code: 3uli: Bromine binding site 1 out of 1 in 3uliGo back to![]() ![]()
Bromine binding site 1 out
of 1 in the Human Cyclin Dependent Kinase 2 (CDK2) Bound to Azabenzimidazole Derivative
![]() Mono view ![]() Stereo pair view
Reference:
T.Wang,
M.A.Block,
S.Cowen,
A.M.Davies,
E.Devereaux,
L.Gingipalli,
J.Johannes,
N.A.Larsen,
Q.Su,
J.A.Tucker,
D.Whitston,
J.Wu,
H.J.Zhang,
M.Zinda,
C.Chuaqui.
Discovery of Azabenzimidazole Derivatives As Potent, Selective Inhibitors of TBK1/Ikk Epsilon Kinases. Bioorg.Med.Chem.Lett. V. 22 2063 2012.
Page generated: Mon Jul 7 06:01:51 2025
ISSN: ISSN 0960-894X PubMed: 22305584 DOI: 10.1016/J.BMCL.2012.01.018 |
Last articlesFe in 2YXOFe in 2YRS Fe in 2YXC Fe in 2YNM Fe in 2YVJ Fe in 2YP1 Fe in 2YU2 Fe in 2YU1 Fe in 2YQB Fe in 2YOO |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |